Grey Fox Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
Grey Fox Wealth Advisors's GILD Position: Q2 2026 in Review
Grey Fox Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,705 shares — an estimated $238K sold.
Grey Fox Wealth Advisors first reported a position in GILD in Q4 2022 and held it in 12 quarters. The position peaked at $522K in Q4 2022. 536 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Grey Fox Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Grey Fox Wealth Advisors sold 1,705 Gilead Sciences shares in Q2 2026, an estimated $238K.
- Grey Fox Wealth Advisors first reported a position in Gilead Sciences in Q4 2022 and held it in 12 quarters.
- Grey Fox Wealth Advisors's Gilead Sciences position peaked at $522K in Q4 2022.
- 536 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Grey Fox Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.